Statistically, the most significant differences in the frequency of P/LP germline variants between patients and population-matched non-cancer controls were detected in PMS2, DNAJC21 (truncating variants only), and MUTYH (OR ranging from 4.1 to 48.9) (Supplementary Table S7). Here, PMS2 is linked to cancer.